Teppo L N Järvinen1, Raine Sihvonen2, Mohit Bhandari3, Sheila Sprague3, Antti Malmivaara4, Mika Paavola5, Holger J Schünemann6, Gordon H Guyatt7. 1. Department of Orthopaedics and Traumatology, Helsinki University Central Hospital, Töölö Hospital, Topeliuksenkatu 5, 00260 Helsinki, Finland; Department of Clinical Sciences, University of Helsinki, Tukholmankatu 8 B, PL 20 Biomedicum, Helsinki, Finland. 2. Department of Orthopaedics and Traumatology, Hatanpää City Hospital, Hatanpäänkatu 24, 33900 Tampere, Finland. 3. Department of Clinical Epidemiology & Biostatistics, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S4L8, Canada; Division of Orthopaedic Surgery, Department of Surgery, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S4L8, Canada. 4. Centre for Health and Social Economics, National Institute for Health and Welfare, Mannerheimintie 166 I, 00271 Helsinki, Finland. 5. Department of Orthopaedics and Traumatology, Helsinki University Central Hospital, Töölö Hospital, Topeliuksenkatu 5, 00260 Helsinki, Finland. 6. Department of Clinical Epidemiology & Biostatistics, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S4L8, Canada; Department of Medicine, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S4L8, Canada. 7. Department of Clinical Epidemiology & Biostatistics, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S4L8, Canada; Department of Medicine, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S4L8, Canada. Electronic address: guyatt@mcmaster.ca.
Abstract
OBJECTIVE: Controversial and misleading interpretation of data from randomized trials is common. How to avoid misleading interpretation has received little attention. Herein, we describe two applications of an approach that involves blinded interpretation of the results by study investigators. STUDY DESIGN AND SETTINGS: The approach involves developing two interpretations of the results on the basis of a blinded review of the primary outcome data (experimental treatment A compared with control treatment B). One interpretation assumes that A is the experimental intervention and another assumes that A is the control. After agreeing that there will be no further changes, the investigators record their decisions and sign the resulting document. The randomization code is then broken, the correct interpretation chosen, and the manuscript finalized. Review of the document by an external authority before finalization can provide another safeguard against interpretation bias. RESULTS: We found the blinded preparation of a summary of data interpretation described in this article practical, efficient, and useful. CONCLUSIONS: Blinded data interpretation may decrease the frequency of misleading data interpretation. Widespread adoption of blinded data interpretation would be greatly facilitated were it added to the minimum set of recommendations outlining proper conduct of randomized controlled trials (eg, the Consolidated Standards of Reporting Trials statement).
OBJECTIVE: Controversial and misleading interpretation of data from randomized trials is common. How to avoid misleading interpretation has received little attention. Herein, we describe two applications of an approach that involves blinded interpretation of the results by study investigators. STUDY DESIGN AND SETTINGS: The approach involves developing two interpretations of the results on the basis of a blinded review of the primary outcome data (experimental treatment A compared with control treatment B). One interpretation assumes that A is the experimental intervention and another assumes that A is the control. After agreeing that there will be no further changes, the investigators record their decisions and sign the resulting document. The randomization code is then broken, the correct interpretation chosen, and the manuscript finalized. Review of the document by an external authority before finalization can provide another safeguard against interpretation bias. RESULTS: We found the blinded preparation of a summary of data interpretation described in this article practical, efficient, and useful. CONCLUSIONS: Blinded data interpretation may decrease the frequency of misleading data interpretation. Widespread adoption of blinded data interpretation would be greatly facilitated were it added to the minimum set of recommendations outlining proper conduct of randomized controlled trials (eg, the Consolidated Standards of Reporting Trials statement).
Authors: Lasse Rämö; Bakir O Sumrein; Vesa Lepola; Tuomas Lähdeoja; Jonas Ranstam; Mika Paavola; Teppo Järvinen; Simo Taimela Journal: JAMA Date: 2020-05-12 Impact factor: 56.272
Authors: Liam D A Paget; Gustaaf Reurink; Robert-Jan de Vos; Adam Weir; Maarten H Moen; Sita M A Bierma-Zeinstra; Sjoerd A S Stufkens; Gino M M J Kerkhoffs; Johannes L Tol Journal: JAMA Date: 2021-10-26 Impact factor: 56.272
Authors: Morten Fenger; Jane Lindschou; Christian Gluud; Per Winkel; Lise Jørgensen; Sten Kruse-Blinkenberg; Marianne Lau Journal: Trials Date: 2016-10-28 Impact factor: 2.279
Authors: Carina Sjöberg Brixval; Lau Caspar Thygesen; Solveig Forberg Axelsen; Christian Gluud; Per Winkel; Jane Lindschou; Tom Weber; Pernille Due; Vibeke Koushede Journal: BMJ Open Date: 2016-06-10 Impact factor: 2.692